• OPTN share price: temporarily unavailable. We are sorry, but this information is temporarily unavailable.

  • OPTN stock price change: temporarily unavailable. We are sorry, but this information is temporarily unavailable.

  • OPTN market open/close: temporarily unavailable. We are sorry, but this information is temporarily unavailable.

Key terms

About OPTN

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

  • OPTN market cap: currently unavailable. Sorry, we currently don't have enough data to create an insight.

Key terms

Smart score

Latest OPTN news

May 21, 2025 8:57am ET Optinose Acquired by Paratek Pharmaceuticals for $330 Million by TipRanks May 21, 2025 8:30am ET Paratek Pharmaceuticals completes acquisition of Optinose by TipRanks May 19, 2025 6:27am ET Hold Rating for Optinose Amid Acquisition Uncertainty and Financial Concerns by TipRanks May 16, 2025 12:57pm ET Optinose Stockholders Approve Merger with Paratek by TipRanks May 15, 2025 9:00am ET Analysts Offer Insights on Healthcare Companies: Celcuity (CELC), InfuSystem Holdings (INFU) and Optinose (OPTN) by TipRanks Mar 27, 2025 11:53pm ET Optinose Reports Revenue Growth Amid Financial Challenges by TipRanks Mar 21, 2025 6:15am ET Optinose downgraded to Neutral from Buy at H.C. Wainwright by TipRanks Mar 20, 2025 12:20pm ET Optinose downgraded to Neutral from Overweight at Piper Sandler by TipRanks Mar 20, 2025 8:55am ET Hold Rating Issued Amid Optinose Acquisition by Paratek Pharmaceuticals with Adjusted Price Target by TipRanks Mar 20, 2025 8:45am ET Optinose downgraded to Hold from Buy at Lake Street by TipRanks Mar 20, 2025 5:55am ET Paratek Pharmaceuticals to acquire Optinose in $330M transaction by TipRanks Mar 04, 2025 9:41am ET OptiNose trading resumes by TipRanks Mar 04, 2025 9:37am ET OptiNose trading halted, volatility trading pause by TipRanks
Mar 20, 2025 5:32pm ET SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating OptiNose, Inc. Buyout by Newsfile Mar 19, 2025 9:45pm ET Optinose Cancels Fourth Quarter and Full Year 2024 Earnings Call by GlobeNewswire Mar 11, 2025 4:15pm ET Optinose Announces Reporting Date for Fourth Quarter and Full Year 2024 Financial Results by GlobeNewswire Jan 15, 2025 7:00am ET Optinose Announces Preliminary Unaudited Fourth Quarter 2024 XHANCE Net Revenue of $22.4 Million by GlobeNewswire Dec 26, 2024 7:00am ET Optinose Announces 1-for-15 Reverse Stock Split by GlobeNewswire Dec 02, 2024 3:53pm ET Optinose to Present at the Piper Sandler 36th Annual Healthcare Conference by GlobeNewswire

OPTN Financials

1-year income & revenue

  • OPTN total revenue: temporarily unavailable. We are sorry, but this information is temporarily unavailable.

  • OPTN net income: temporarily unavailable. We are sorry, but this information is temporarily unavailable.

  • OPTN earnings per share: temporarily unavailable. We are sorry, but this information is temporarily unavailable.

Key terms

OPTN Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

OPTN Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

  • OPTN competitors: temporarily unavailable. We are sorry, but this information is temporarily unavailable.

  • OPTN market cap: currently unavailable. Sorry, we currently don't have enough data to create an insight.

Key terms

Latest investing news